Ludwig-McGill HPV Cohort
Ludwig-McGill HPV Cohort
The Ludwig-McGill HPV Cohort is a significant research study focused on the natural history of human papillomavirus (HPV) infection and its role in the development of cervical cancer. This cohort study is a collaborative effort between the Ludwig Institute for Cancer Research and McGill University.
Background[edit | edit source]
The study was initiated to better understand the epidemiology of HPV, a virus that is known to cause cervical cancer. The cohort consists of a large group of women who have been followed over time to observe the progression of HPV infection and its potential to cause cervical lesions and cancer.
Study Design[edit | edit source]
The Ludwig-McGill HPV Cohort is a prospective cohort study. Participants were recruited from various clinics and have been monitored through regular follow-ups. The study collects data on HPV infection status, cervical cytology, and other relevant health information.
Objectives[edit | edit source]
The primary objectives of the study include:
- To determine the incidence and duration of HPV infections.
- To identify factors that influence the persistence and clearance of HPV.
- To assess the risk of progression from HPV infection to cervical intraepithelial neoplasia and cervical cancer.
Findings[edit | edit source]
The study has provided valuable insights into the natural history of HPV. Key findings include:
- The identification of specific HPV types that are more likely to persist and lead to cervical cancer.
- The role of co-factors such as smoking and oral contraceptive use in the progression of HPV-related lesions.
Impact[edit | edit source]
The findings from the Ludwig-McGill HPV Cohort have contributed to the development of HPV vaccines and screening programs. The study has also influenced public health policies regarding cervical cancer prevention.
Related pages[edit | edit source]
Template:Ludwig Institute for Cancer Research Template:McGill University
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD